In the US, Plavix (clopidogrel systemic) is a member of the drug class platelet aggregation inhibitors and is used to treat Acute Coronary Syndrome, Acute Coronary Syndrome - Prophylaxis, Heart Attack, Ischemic Stroke, Ischemic Stroke - Prophylaxis, Myocardial Infarction - Prophylaxis, Percutaneous Coronary Intervention, Peripheral Arterial Disease, Platelet Aggregation Inhibition and Transient Ischemic Attack.
Ingredient matches for Plavix
Clopidogrel is reported as an ingredient of Plavix in the following countries:
Clopidogrel hydrogen sulfate (a derivative of Clopidogrel) is reported as an ingredient of Plavix in the following countries:
- Bosnia & Herzegowina
- Dominican Republic
- El Salvador
- Hong Kong
- Russian Federation
- South Africa
- United Kingdom
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.